Diabetologia

Health service utilisation and costs of treatment with either exenatide twice daily or basal insulin for patients with type 2 diabetes: a retrospective UK study

https://www.easd.org/virtualmeeting/home.html#!resources/health-service-utilisation-and-costs-of-treatment-with-either-exenatide-twice-daily-or-basal-insulin-for-patients-with-type-2-diabetes-a-retrospective-uk-study-137bf014-d30c-4474-9565-b387f6bb6c58

Post author By Morgan C L, Jenkins-Jones S, Currie C J, Berni E R, Holden S E and Qiao Q
Post date 9 February 2016

Morgan C L, Jenkins-Jones S, Currie C J, Berni E R, Holden S E, Qiao Q. 09 Feb 2016

Morgan C L

Jenkins-Jones S

Currie C J

Berni E R

Holden S E

Qiao Q

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Site by Create Summit